Target intelligence / Profile preview

SNX29 antisense RNA 2 (SNX29-AS2)

Target
SNX29-AS2
Molecular classification
Other (non-coding RNA, specifically long non-coding RNA / lncRNA)
01

Overview

SNX29 antisense RNA 2 (SNX29-AS2) is a **long non-coding RNA (lncRNA)** transcribed from the strand opposite to the SNX29 (Sorting Nexin 29) gene locus. It does not encode a protein and is not known to be a classical therapeutic target such as a receptor, enzyme, or transporter. While lncRNAs like SNX29-AS2 are sometimes involved in gene regulation through mechanisms such as antisense inhibition, sponging microRNAs, or modulating chromatin structure, there are currently no curated data linking SNX29-AS2 to specific biological functions, disease involvement, biomarkers, or clinically relevant drug interactions in humans[2]. Its classification is as a non-coding RNA, possibly involved in regulatory networks such as the competing endogenous RNA (ceRNA) network, but at present there is insufficient evidence to describe detailed functions or therapeutic roles. If you are seeking data on the protein-coding SNX29 gene (Sorting Nexin 29), this is distinct: SNX29 encodes a protein involved in cellular cargo transport and has been linked to reproductive traits, neurodevelopment, and certain diseases, but SNX29-AS2 refers specifically to its antisense lncRNA transcript[1][3].

Other names
SNX29-AS2SNX29 antisense RNA 2
02

Biological functions

Regulation of gene expression (likely via antisense interaction with SNX29 or acting as competing endogenous RNA)Potential ceRNA network function (competing for microRNAs)Other
03

Disease associations

Other (no direct evidence for classical disease categories from supplied data; potential involvement in regulatory pathways is plausible but not established in current sources)

Beyond the preview

Go deeper on SNX29 antisense RNA 2 (SNX29-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNX29 antisense RNA 2 (SNX29-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call